HC Wainwright & Co. Reiterates Buy on MiMedx Group, Maintains $8 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MiMedx Group (NASDAQ:MDXG) with a Buy and maintains $8 price target.

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MiMedx Group (NASDAQ:MDXG) with a Buy and maintains $8 price target.

Total
0
Shares
Related Posts